SCHEMBL26410686

SCHEMBL26410686

O=C(ON1CC[C@H](C(=O)O)C1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 5/20 0.51
SLC6A1 P30531 2/20 0.45
ALDH1A1 P00352 2/20 0.45
LMNA P02545 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
TSHR P16473 1/20 0.45
NFKB1 P19838 1/20 0.45
CYP2C19 P33261 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
CHRNB2 P17787 1/20 0.43
CHRNA5 P30532 1/20 0.43
CHRNA7 P36544 1/20 0.43
CHRNA4 P43681 1/20 0.43
S1PR5 Q9H228 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19186103 0.90 RAB9A (0.47) NOTUMALDH1A1LMNACYP2C19MEN1
SCHEMBL26545466 0.87 F2 (0.45) NOTUMLMNATSHRMEN1KMT2A
SCHEMBL26439861 0.83 KMT2A (0.44) LMNACYP2D6TSHRMEN1KMT2A
SCHEMBL27772891 0.83 KMT2A (0.44) ALDH1A1LMNACYP2D6TSHRMEN1
SCHEMBL28781857 0.83 KMT2A (0.44) LMNACYP2D6TSHRMEN1KMT2A
SCHEMBL20306078 0.83 KMT2A (0.44) LMNATSHRMEN1KMT2ACHRNB2
SCHEMBL25629349 0.81 KMT2A (0.47) LMNATSHRMEN1KMT2ACHRNB2
SCHEMBL27808181 0.80 KMT2A (0.43) ALDH1A1TSHRHSD17B10MEN1KMT2A
SCHEMBL29111290 0.79 SLC18A3 (0.57) ALDH1A1LMNAMEN1KMT2ACHRNB2
SCHEMBL20306077 0.79 ALDH1A1 (0.55) ALDH1A1TSHRHSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4169922-A1 FGFR AND MUTATION INHIBITOR THEREOF, AND PREPARATION METHOD THEREFOR AND USE THEREOF Abbisko Therapeutics Co., Ltd. (CN) 2023-04-26 EP disclosed